Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve the unaudited standalone ....
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hester Biosciences has informed the stock exchanges that its Board of Directors will meet on 12 November 2025. The agenda includes considering and approving the unaudited standalone and consolidated financial results for the quarter and six months ended 30 September 2025 (i.e., Q2 FY26 and H1 FY26). This is a routine regulatory filing under SEBI LODR Regulation 29, and no financial numbers or outcomes have been disclosed yet. The results are expected to be announced after the board meeting concludes on 12 November.
This is a standard pre-results intimation with no new information for investors. Watch for the actual results announcement on or shortly after 12 November 2025, which could move the stock depending on the numbers versus expectations.